Nutra Pharma CEO, Rik J. Deitsch, has published a letter to Shareholders outlining the current efforts and the future goals of the Company
Nutra Pharma Corporation (OTCBB: NPHC.OB), a biotechnology company that is developing treatments for Multiple Sclerosis…